Global Public Health Partnering 2010-2016: Deal trends, players and financials

Published: July 2016
No. of Pages: 1000
   

"Delivery of this report will take 1-3 days after purchase."
Summary

Global Public Health Partnering 2010-2016: Deal trends, players and financials provides comprehensive understanding and unprecedented access t- the public health partnering deals and agreements entered int- by the worlds leading healthcare companies

Global Public Health Partnering 2010 t- 2016 provides the full collection of Public Health disease deals signed between the world’s pharmaceutical and biotechnology companies since 2010.

Trends in Public Health partnering deals
Financial deal terms for headline, upfront and royalty by stage of development
Public Health partnering agreement structure
Public Health partnering contract documents
Top Public Health deals by value
Most active Public Health dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right t- license a licensor’s product or technology. More often these days these deals tend t- be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Public Health disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Public Health deals.

The report presents financial deal terms values for Public Health deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers t- analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of Public Health dealmaking trends.

Chapter 1 provides an introduction t- the report.

Chapter 2 provides an overview of the trends in Public Health dealmaking since 2010 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading Public Health deals since 2010. Deals are listed by headline value. The chapter includes the top 25 most active Public Health dealmakers, together with a full listing of deals t- which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access t- the contract.

Chapter 5 provides comprehensive access t- Public Health deals since 2010 where a deal contract is available, providing the user with direct access t- contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink t- an online version of the deal record contract document, providing easy access t- each contract document on demand.

Chapter 6 provides a comprehensive directory of all Public Health partnering deals by specific Public Health target announced since 2010. The chapter is organized by specific Public Health therapeutic target. Each deal title links via Weblink t- an online version of the deal record and where available, the contract document, providing easy access t- each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all Public Health partnering deals signed and announced since 2010. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink t- an online version of the deal record and where available, the contract document, providing easy access t- each contract document on demand.

The report als- includes numerous tables and figures that illustrate the trends and activities in Public Health partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs t- know about partnering in the research, development and commercialization of Public Health technologies and products.

Report scope

Global Public Health Partnering 2010 t- 2016 is intended t- provide the reader with an in-depth understanding and access t- Public Health trends and structure of deals entered int- by leading companies worldwide.

Global Public Health Partnering 2010 t- 2016 includes:

Trends in Public Health dealmaking in the biopharma industry since 2010
Analysis of Public Health deal structure
Access t- headline, upfront, milestone and royalty data
Access t- hundreds of Public Health deal contract documents
Comprehensive access t- over 3500 Public Health deal records
The leading Public Health deals by value since 2010
Most active Public Health dealmakers since 2010

In Global Public Health Partnering 2010 t- 2016, available deals and contracts are listed by:

Headline value
Upfront payment value
Royalty rate value
Stage of development at signing
Deal component type
Technology type
Specific therapy indication

Each deal title links via Weblink t- an online version of the deal record and where available, the contract document, providing easy access t- each contract document on demand.

The Global Public Health Partnering 2010-2016 report provides comprehensive access t- available deals and contract documents for over 200 public health deals. Analyzing actual contract agreements allows assessment of the following:

What are the precise rights granted or optioned?
What is actually granted by the agreement t- the partner company?
What exclusivity is granted?
What is the payment structure for the deal?
How are the sales and payments audited?
What is the deal term?
How are the key terms of the agreement defined?
How are IPRs handled and owned?
Wh- is responsible for commercialization?
Wh- is responsible for development, supply, and manufacture?
How is confidentiality and publication managed?
How are disputes t- be resolved?
Under what conditions can the deal be terminated?
What happens when there is a change of ownership?
What sublicensing and subcontracting provisions have been agreed?
Which boilerplate clauses does the company insist upon?
Which boilerplate clauses appear t- differ from partner t- partner or deal type t- deal type?
Which jurisdiction does the company insist upon for agreement law?
Global Public Health Partnering 2010 t- 2016 provides the reader with the following key benefits:

In-depth understanding of Public Health deal trends since 2010
Access Public Health deal headline, upfront, milestone and royalty data
Research hundreds of actual contracts between Public Health partner companies
Comprehensive access t- over 750 links t- actual Public Health deals entered int- by the world’s biopharma companies
Indepth review of Public Health deals entered int- by the top 25 most active dealmakers
Benchmark the key deal terms companies have agreed in previous deals
Identify key terms under which companies partner Public Health opportunities
Uncover companies actively partnering Public Health opportunities

Global Public Health Partnering 2010-2016: Deal trends, players and financials

Table of Contents


Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in Public Health dealmaking

2.1. Introduction
2.2. Public Health partnering over the years
2.3. Public Health partnering by deal type
2.4. Public Health partnering by industry sector
2.5. Public Health partnering by stage of development
2.6. Public Health partnering by technology type
2.7. Public Health partnering by therapeutic indication

Chapter 3 –Financial deal terms for Public Health partnering

3.1. Introduction
3.2. Disclosed financials terms for Public Health partnering
3.3. Public Health partnering headline values
3.4. Public Health deal upfront payments
3.5. Public Health deal milestone payments
3.6. Public Health royalty rates

Chapter 4 – Leading Public Health deals and dealmakers

4.1. Introduction
4.2. Most active in Public Health partnering
4.3. List of most active dealmakers in Public Health
4.4. Top Public Health deals by value

Chapter 5 – Public Health contract document directory

5.1. Introduction
5.2. Public Health partnering deals where contract document available

Chapter 6 – Public Health dealmaking by therapeutic target

6.1. Introduction
6.2. Deals by Public Health therapeutic target

Appendices

Appendix 1 – Directory of Public Health deals by company A-Z 2010 to 2016
Appendix 2 – Directory of Public Health deals by deal type 2010 to 2016
Appendix 3 – Directory of Public Health deals by stage of development 2010 to 2016
Appendix 4 – Directory of Public Health deals by technology type 2010 to 2016
Further reading on dealmaking
Deal type definitions

About Wildwood Ventures

Current Partnering
Current Agreements
Recent report titles from CurrentPartnering

Table of figures

Figure 1: Public Health partnering since 2010
Figure 2: Public Health partnering by deal type since 2010
Figure 3: Public Health partnering by industry sector since 2010
Figure 4: Public Health partnering by stage of development since 2010
Figure 5: Public Health partnering by technology type since 2010
Figure 6: Public Health partnering by indication since 2010
Figure 7: Public Health deals with a headline value
Figure 8: Public Health deals with upfront payment values
Figure 9: Public Health deals with milestone payment
Figure 10: Public Health deals with royalty rates
Figure 11: Active Public Health dealmaking activity– 2010 to 2016
Figure 12: Top Public Health deals by value since 2010

Published By: Current Partnering
Product Code: Current Partnering521


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and we�ll share relevant market report titles for you to explore.

Related Reports:


Why ReportsnReports.com?

  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Healthcare market as per your needs. Get the best of Healthcare research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest: